S2Medical AB Class B (S21) AI Stock Analysis

S2Medical AB Class B

(Frankfurt:S21)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Long-term revenue growthThe substantial multi-year revenue increase indicates that S2Medical has expanded its commercial base and product adoption. Although recent growth has weakened, the larger revenue platform provides a foundation for recovery if execution and demand stabilize.

Negative Factors

Volatile revenue trajectoryThe reversal from strong growth to declines reduces confidence in demand durability and forecasting reliability. Continued volatility could weaken operating leverage, make resource planning harder, and delay the ability to convert the expanded revenue base into consistent returns.

S2Medical AB Class B (S21) vs. iShares MSCI Germany ETF (EWG)

Not enough price history over this period.

Market Cap: EUR 628.72K
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -0.3
Beta (1Y): 13.32
Revenue Growth: ―
EPS Growth: ―
Country: Germany
Employees: 10
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Instruments & Supplies

S2Medical AB Class B Business Overview & Revenue Model

Company Description

S2Medical AB (publ) focuses on the development, production, and commercialization of advanced wound care solutions, specifically targeting burns and chronic wounds. Their product range features INSTAQRETT, a sterile, disposable tool for mechanical de...

S2Medical AB Class B Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:S21 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:STIL	81Outperform	SEK 2.23B	23.18	―	―	28.75%	138.25%
SE:ALIF.B	74Outperform	SEK 22.23B	34.66	11.32%	0.82%	1.62%	63.45%
SE:ARJO.B	69Neutral	SEK 9.18B	25.35	4.65%	2.82%	-0.50%	-17.58%
SE:BACTI.B	53Neutral	SEK 560.70M	88.89	1.93%	―	-0.51%	―
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:SEDANA	49Neutral	SEK 926.81M	-26.86	-3.88%	―	0.42%	15.03%

* Healthcare Sector Average

Performance Comparison

DE:S21 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:S21	S2Medical AB Class B	―	―	―
SE:ALIF.B	AddLife AB Class B	182.30	-14.65	-7.44%
SE:ARJO.B	Arjo AB Class B	33.72	3.94	13.22%
SE:BACTI.B	Bactiguard Holding AB	16.00	-0.20	-1.23%
SE:SEDANA	Sedana Medical AB	9.33	-0.75	-7.44%
SE:STIL	Stille AB	248.50	72.00	40.79%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

S2Medical AB Class B AI Stock Analysis